Companies / Dr Reddys Laboratories Ltd

Dr Reddys Laboratories Ltd

NYSE: RDYCIK 1135951HYDERABADdrreddys.com

Financials · FY2025

Revenue$3.81B
Net income$671.00M
Total debt
Cash$172.00M
Diluted EPS$0.79
Shares outstanding834.7M

Ownership

834.7M shares outstanding
13.3%Institutions
Ownership
Institutions13.33%111,272,962
Public float86.67%723,384,008

% of common shares outstanding (single-class filing figure). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 19

View all →
Insider% of sharesShares
Aghanian Patrick RudolfHead - Europe Generics
Bhethanabottla Srinivasa PhanimitraChief Information Officer
Israeli ErezCEOCHIEF EXECUTIVE OFFICER
Kalawadia Milan KantilalCEOCEO - North America
Kulkarni SushrutGLOBAL HEAD - IPDO
Mannam Venkata NarasimhamChief Financial Officer
Motupalli Venkata RamanaCEOCEO - Global Generics

Institutional holders 246

View all →

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
No activity matches these filters.

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
RDYADREquity256135203BBG000NJ96L6